Biogen Inc. (BIIB)
NASDAQ·Healthcare·Drug Manufacturers - General
$198.01
+1.33%
Mkt Cap $29.33B
Analyst Ratings
Buy
18
Hold
17
Sell
0
Price Target (117 analysts)
$207.60
Range $143.00 – $250.00
Implied Upside
+4.8%
Consensus $207.60 vs current $198.01